GlassScriptPhysician profile
Andrew Maxwell Krane
NPI 1043884372
$1,846.24
in general payments reported to CMS, 2019-2025
18 companies · $1,474 in 2025
The $1,474 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $373 · 2025: $1,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $639.69 | 2024-2025 | |
| Daiichi Sankyo INC. | $238.03 | 2024-2025 | Injectafer |
| Gilead Sciences, INC. | $224.04 | 2024-2025 | Livdelzi |
| Madrigal Pharmaceuticals | $110.40 | 2025 | Rezdiffra |
| Ardelyx, INC. | $107.24 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.15 | 2024-2025 | Xifaxan |
| Mallinckrodt Hospital Products INC. | $79.92 | 2025 | Terlivaz |
| Ipsen Biopharmaceuticals, INC | $67.45 | 2025 | Iqirvo |
| Takeda Pharmaceuticals U.S.A., INC. | $66.89 | 2025 | Eohilia, Entyvio |
| Janssen Biotech, INC. | $39.76 | 2025 | Simponi Aria, Stelara, Simponi |
| Janssen Scientific Affairs, LLC | $32.17 | 2024-2025 | Tremfya |
| Exact Sciences Corporation | $32.09 | 2025 | Cologuard Collection Kit |
| Olympus America INC. | $25.76 | 2025 | Hanarostent Esophagus Tts(Ccc) |
| Astrazeneca Pharmaceuticals LP | $24.95 | 2024 | |
| Intercept Pharmaceuticals, INC. | $20.26 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $18.04 | 2025 | Hyrimoz |
| Biocon Biologics INC | $17.11 | 2025 | Yesintek |
| Medtronic, INC. | $15.29 | 2024 | Nexpowder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Krane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.